Goldman dominates first-half M&A as dealmaking surges in EMEA

Goldman Sachs increased its EMEA M&A advisory market share to 44% by deal value in H1 2026, advising 111 deals, as regional dealmaking rose to $676B—more than double 2025 levels and a 19-year high. The uptick is tied to looser regulatory constraints, though markets remain volatile and league-table rankings could shift if deals fall out. Largest deals included Goldman’s work on Unilever’s ~$45B sale of its food business to McCormick and TK Elevators’ $34B combination with Kone.

Analysis

The key market signal is not “more M&A,” but a rotation toward larger, fee-dense mandates where Goldman’s franchise has the highest operating leverage. That matters because advisory revenue scales almost entirely into pretax income; a sustained 40%+ share of EMEA value should support estimates even if overall capital markets remain uneven. The cleaner beneficiary is GS vs. banks whose league-table strength is breadth, not mega-deal capture, because the fee pool is concentrating at the top end.

The second-order read is that Europe’s regulatory thaw can sustain a 6-18 month upgrade cycle for advisory desks, but the near-term P&L benefit is delayed until transactions close. That makes the next 1-3 months about pipeline validation: if announced deals convert, analysts will raise FY26 IB fee estimates; if approvals slip, the “share gain” becomes headline noise. JPMorgan is the closest relative competitor, but its narrower edge in count over value suggests it is winning lower-fee density work, which is less helpful for earnings leverage.

Contrarian risk: league tables are highly unstable and can reverse quickly if a handful of large deals break or reprice. The consensus may be overcalling durability because headline market share is based on announced value, not completed fees, and the environment is still vulnerable to antitrust, financing, or board-level delays. The clean falsifier is a drop in announced-to-closed conversion or a visible fade in EMEA mega-deal announcements over the next quarter.

Key Decisions for Investors

• Long GS vs. short JPM as a 1-3 month relative-value pair: GS has better exposure to mega-deal fee density, while JPM’s share mix appears more count-heavy; target 3-5% alpha if EMEA closings stay constructive.
• Add GS on pullbacks ahead of the next earnings/guidance update: the setup is an estimate-revision story, not an immediate revenue story; best entry is on any post-headline fade rather than chasing strength.
• Use XLF as a hedge if taking standalone GS exposure: the trade is franchise-specific, and broad financials won’t capture the incremental M&A mix benefit; stop if EMEA deal announcements roll over for a full quarter.
• Watch for a catalyst in closed-deal data over the next 1-3 months; if announced EMEA value remains strong but closures stall, fade the move and rotate into boutiques like EVR/LAZ rather than universal banks.